Your browser doesn't support javascript.
loading
Prospective Hemophilia Inhibitor PUP Study reveals distinct antibody signatures during FVIII inhibitor eradication.
Paul, Helmut; Berg, Verena; Gangadharan, Bagirath; Bowen, Joel; LeBeau, Petra; Blatný, Jan; Male, Christoph; Radulescu, Vlad C; Diaz, Rosa; Mancuso, Maria Elisa; Brown, Deborah L; Reipert, Birgit M.
Afiliación
  • Paul H; Institute Krems Bioanalytics, IMC University of Applied Sciences Krems, Krems, Austria.
  • Berg V; Institute Krems Bioanalytics, IMC University of Applied Sciences Krems, Krems, Austria.
  • Gangadharan B; Baxalta Innovations GmbH, Vienna, Austria.
  • Bowen J; Indiana Hemophilia and Thrombosis Center Inc., Indianapolis, IN.
  • LeBeau P; Rho Inc., Durham, NC.
  • Blatný J; Department of Paediatric Haematology, University Hospital Brno, Masaryk University, Brno, Czech Republic.
  • Male C; Department of Pediatrics, Medical University of Vienna, Vienna, Austria.
  • Radulescu VC; Hemophilia Treatment Center, University of Kentucky, Lexington, KY.
  • Diaz R; Baylor College of Medicine, Houston, TX.
  • Mancuso ME; IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy.
  • Brown DL; Fondazione Ca' Granda, Ospedale Maggiore Policlinico, Milan, Italy.
  • Reipert BM; University of Texas Health Science Center, Houston, TX.
Blood Adv ; 7(9): 1831-1848, 2023 05 09.
Article en En | MEDLINE | ID: mdl-36074992

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Hemostáticos / Hemofilia A Tipo de estudio: Risk_factors_studies Límite: Humans Idioma: En Revista: Blood Adv Año: 2023 Tipo del documento: Article País de afiliación: Austria

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Hemostáticos / Hemofilia A Tipo de estudio: Risk_factors_studies Límite: Humans Idioma: En Revista: Blood Adv Año: 2023 Tipo del documento: Article País de afiliación: Austria